首页> 外国专利> Polyureas and their use as postoperative adhesion barriers, films and composites

Polyureas and their use as postoperative adhesion barriers, films and composites

机译:聚脲及其作为术后粘连屏障,薄膜和复合材料的用途

摘要

Polyurea system comprises: (a) an amino functional aspartic acid (I); (b) an isocyanate functional prepolymer, with a residual monomer content of less than 1 wt.%, obtained by reacting (b1) aliphatic isocyanate with (b2) a polyol component with a number average molecular weight of greater than 400 g/mol and an average hydroxyl-functionality of 2-6 and comprises polyesterpolyol and/or polyester-polyether-polyol and optionally polyetherpolyol; and/or (c) optionally organic filler; and (d) optionally the reaction product of component (b) with component (a) and/or component (c). Polyurea-system comprises: (a) an amino functional aspartic acid of formula (X[-NH-CH(-CH 2-COOR 2)-COOR 1] n) (I); and (b) an isocyanate functional prepolymer, with residual monomer content of less than 1 wt.%, obtained by reacting (b1) aliphatic isocyanate with (b2) a polyol component with a number average molecular weight of greater than 400 g/mol and an average hydroxyl-functionality of 2-6 and comprises polyesterpolyol and/or polyester-polyether-polyol and optionally polyetherpolyol; and/or (c) optionally organic filler having viscosity, measured according to DIN 53019 at 23[deg] C, of 10-6000 mPas; and (d) optionally the reaction product of component (b) with component (a) and/or component (c). X : n-valenced organic residue, obtained by removing the primary amino group of n-valenced amine; R 1, R 2organic residue comprising no Zerewitinoff-active hydrogen; and n : whole number of at least 2. Independent claims are included for: (1) preparing the polyurea system, comprising mixing the components (a), (b), and optionally (c) and (d), where the ratio of free or blocked amino groups to free isocyanate groups is 1:1 and the weight ratio of the component (c) to component (a) is 0:1-20:1; and (2) a 2-chamber dosing system comprising the polyurea system, where one chamber comprises the component (a) and the other chamber comprises the harder component (b) and optional components (c) and (d).
机译:聚脲系统包含:(a)氨基官能的天冬氨酸(I); (b)通过使(b1)脂族异氰酸酯与(b2)数均分子量大于400g / mol的多元醇组分反应得到的,具有残留单体含量小于1wt。%的异氰酸酯官能预聚物。平均羟基官能度为2-6,并且包括聚酯多元醇和/或聚酯-聚醚多元醇和任选的聚醚多元醇;和/或(c)任选地有机填料; (d)任选地,组分(b)与组分(a)和/或组分(c)的反应产物。聚脲体系包含:(a)式(X [-NH-CH(-CH 2 -COOR 2)-COOR 1] n)的氨基官能的天冬氨酸(I); (b)通过使(b1)脂族异氰酸酯与(b2)数均分子量大于400 g / mol的多元醇组分反应制得的,残留单体含量小于1 wt。%的异氰酸酯官能预聚物。平均羟基官能度为2-6,并且包括聚酯多元醇和/或聚酯-聚醚多元醇和任选的聚醚多元醇;和/或(c)任选的有机填料,其根据DIN 53019在23℃下测量的粘度为10-6000mPas; (d)任选地,组分(b)与组分(a)和/或组分(c)的反应产物。 X:通过除去n价胺的伯氨基获得的n价有机残基; R 1,R 2不包含Zerewitinoff活性氢的有机残基; n为至少2的整数。独立权利要求包括:(1)制备聚脲体系,包括混合组分(a),(b)和可选的(c)和(d),其中游离或封闭的氨基与游离异氰酸酯基的比例为1∶1,组分(c)与组分(a)的重量比为0∶1〜20∶1。 (2)一种包括聚脲系统的2室加药系统,其中一个室包含组分(a),另一个室包含较硬的组分(b)和任选的组分(c)和(d)。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号